Bethyl Laboratories
Rabbit anti-CTCF IHC Antibody Affinity Purified
Primary
Catalog #IHC-00046
TargetCTCF
HostRabbit
ClonalityPolyclonal
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
Order within 4 hours and 37 minutes for shipment by today
Product Description
CTCF is a versatile 11-Zn-finger transcription factor that may function as a repressor of transcription, activator transcription, or regulator of genomic imprinting. CTCF is a candidate tumor suppressor associated with invasive breast cancer, prostate cancer, and Wilm’s tumor.
Specifications
Clonality
Polyclonal
Host
Rabbit
Immunogen
Between 677 and C-terminus
Isotype
IgG
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Antigen Affinity Purified
Concentration
250 µg/ml
Target Identity
TargetCTCF
Antigen Species
Human
Gene ID10664
Gene Symbol
CTCF
Gene Name
CCCTC-binding factor
Uniprot IDP49711
Protein Name
Transcriptional repressor CTCF
Product Information
Applications
IHC
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Antibody was affinity purified using an epitope specific to CTCF immobilized on solid support.
The epitope recognized by IHC-00046 maps to a region between residue 650 and 700 of human CCCTC-binding factor using the numbering given in entry NP_006556.1 (GeneID 10664).
Applications
Epitope exposure is recommended.
Epitope exposure with citrate buffer will enhance staining.
Likely to work with frozen sections.
In some cases, the antibody may be diluted further than indicated.
Immunohistochemistry (IHC)1:100 - 1:500
Documents
Safety Data SheetPDF · IHC-00046Open
Product DatasheetPDF · IHC-00046 · Lot 1 (current lot)Open
Product DatasheetPDF · IHC-00046 · Lot 1 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1